Showing results (241-250 of 287) with videos related to
Sort By:
Pageof 29
Allergy|June 3, 2011
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*Marek L Kowalski, J S Makowska, M Blanca, et al.Allergy|February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position PaperM H Shamji, J H Kappen, M Akdis, et al.Allergy|November 25, 2017
Perspectives in allergen immunotherapy: 2017 and beyondO Pfaar, S Bonini, V Cardona, et al.Allergy|March 19, 2016
In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paperC Mayorga, G Celik, P Rouzaire, et al.Allergy|September 15, 2017
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK studyJ Bousquet, S Arnavielhe, A Bedbrook, et al.Clinical and Translational Allergy|June 3, 2017
Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force ReportC Cingi, P Gevaert, R Mösges, et al.Journal of Investigational Allergology & Clinical Immunology|November 10, 2018
Epidemiological Data on Anaphylaxis in French Emergency DepartmentsJ Corriger, E Beaudouin, R Rothmann, et al.Allergy|January 14, 2014
EAACI position statement on asthma exacerbations and severe asthmaA Custovic, S L Johnston, I Pavord, et al.Tuberkuloz Ve Toraks|May 5, 2012
[ARIA (Allergic Rhinitis and its Impact on Asthma) achievements in 10 years and future needs]A Yorgancıoğlu, C Özdemir, Ö Kalaycı, et al.Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.Pageof 29